Skip to main content

Table 3 Acquired antimicrobial resistance genes of 38 clinical E. coli isolates

From: Whole genome sequencing reveals high clonal diversity of Escherichia coli isolated from patients in a tertiary care hospital in Moshi, Tanzania

Isolate

AMGa

BLb

FQAc

Macrolide

Phenicol

Quinolone

Sulphonamide

Tetracycline

Trimethoprim

4

strA strB

blaTEM-1B

    

sul2

 

dfrA14

5

6

10

 

blaOXA-1

aac(6’)Ib-cr

 

catB3

  

tet(A)

 

21

strA strB

     

sul2

tet(A)

dfrA14

22

 

blaOXA-1

aac(6’)Ib-cr

 

catB3

  

tet(A)

 

30

44

aac(3)-IId aadA2

blaCTX-M-15 blaTEM-1B

 

mph(A)

catA1

QnrS1 qepA QnrD

sul1

tet(A)

dfrA12

70

aadA5

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul1

tet(A)

dfrA17

73

aadA5

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul1

tet(A)

dfrA17

82

strA strB aadA2

blaTEM-1B

 

mph(A)

  

sul2 sul1

tet(B) tet(A)

dfrA12

97

 

blaOXA-1

aac(6’)Ib-cr

 

catB3

  

tet(B)

 

115

aadA1 aac(3)-IIa strB strA

blaCTX-M-15 blaTEM-1B blaOXA-1

aac(6’)Ib-cr

 

catB3 catA1

QnrB1

sul2

 

dfrA14

163A

199

aadA1 strB strA aadA5 aadB

blaCTX-M-15 blaTEM-1B blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3 cmlA1

 

sul1 sul2

tet(A)

dfrA17

203

strB strA

blaTEM-1C blaOXA-1

aac(6’)Ib-cr

 

catB3

 

sul2

tet(A)

dfrA14

210

aadA5 aac(3)-IIa strB strA

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul1 sul2

tet(A)

dfrA17

237C

aac(3)-Iia aadA5 strA strB

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul1 sul2

tet(B)

dfrA17

244

aac(3)-IIa aadA5 strA strB

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul2 sul1

tet(B)

dfrA17

245

strA aac(3)-IIa strB aadA5

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul1 sul2

tet(B)

dfrA17

247

strA strB aadA5

blaOXA-1 blaCTX-M-15

aac(6’)Ib-cr

mph(A)

catB3

 

sul2 sul1

tet(A)

dfrA17

298

strB strA

blaTEM-1B

  

catA1

 

sul2

tet(D)

dfrA7

365

aadA5

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul1

tet(A)

dfrA17

393

aac(3)-Iia aadA5

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul1

tet(B)

dfrA17

431D

erm(B) strA strB

     

sul2

  

521

      

sul2 sul1

 

dfrA5

538

aac(3)-Iia aadA5 strA strB

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul1 sul2

tet(A) tet(B)

dfrA17

554

strA strB

blaTEM-1B

    

sul2

 

dfrA5

567B

aadA5

  

mph(A)

  

sul1

 

dfrA17

587

aadA5

blaCTX-M-15

 

mph(A)

  

sul1

 

dfrA17

603

strB aadA5 aac(3)-IId strA

blaTEM-1B

 

mph(A)

  

sul2 sul1

 

dfrA17

118A

strB strA

blaTEM-1B

    

sul1 sul2

 

dfrA7

119EC

340B

strB strA

     

sul2

tet(A)

dfrA14

598A

strB strA

blaTEM-1B

 

mph(A)

  

sul2

tet(B)

dfrA17

598B

aac(3)-IIa strB strA

blaTEM-1B blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul2

tet(A)

dfrA14

71E

aadA5 aac(3)-IIa strB strA

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

mph(A)

catB3

 

sul1 sul2

tet(A)

dfrA17

77E

strA strB

blaCTX-M-15 blaOXA-1

aac(6’)Ib-cr

 

catB3

 

sul2

tet(B)

 
  1. a Aminoglycoside
  2. b Beta-Lactam
  3. c Fluoroquinolones and aminoglycoside